AdaptHealth Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AdaptHealth Corp. on September 21, 2020. The filing reports the appointment of a new senior officer effective immediately on the date of the report.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. This report focuses exclusively on executive compensation and appointment details.
Material Changes
The primary material change is the appointment of Frank Mullen as Chief Accounting Officer (CAO). Mr. Mullen joins from Ryder System, Inc., where he served as Senior Vice President and Controller since 2017.
Compensation and Employment Terms
- Base Salary: $295,000 annually.
- Target Bonus: 40% of base salary ($118,000 target), contingent on performance targets.
- Relocation Bonus: One-time payment of $70,000, subject to recoupment if employment terminates within one year.
- Equity Grant: Initial grant of restricted Class A Common Stock valued at $300,000 (based on 20-day VWAP prior to start), vesting over four years.
- Future Equity: Eligible for annual equity grants with a target value of $50,000 commencing in fiscal year 2021.
- Severance: Six months of base salary if terminated without "cause" and subject to a separation agreement.
Outlook and Risks
The filing contains no forward-looking guidance, management commentary on business outlook, or discussion of risks and contingencies beyond standard employment covenants (non-competition, non-solicitation, and confidentiality).
Key Facts for Investor Verification
- Verify the exact number of shares issued for the $300,000 initial equity grant based on the stock price on September 21, 2020.
- Confirm the vesting schedule details for the initial restricted stock grant.
- Review the definition of "cause" in the employment agreement to understand severance triggers.
- Monitor future filings for the actual issuance of the annual $50,000 target equity grants starting in 2021.